CEFPONIL-50 CV DRY SYP
Description
- Contains Cefpodoxime Proxetil 50 mg and Potassium Clavulanate 31.25 mg per 5 ml
- Broad-spectrum antibiotic action with resistance-fighting β-lactamase inhibitor
- Specially formulated for children in a tasty, easy-to-administer suspension
- Effective in treating respiratory, ENT, urinary, and skin infections
- Offers reliable results even in resistant bacterial infections
- Excellent safety and tolerability profile in pediatric patients
- Helps prevent relapse and ensures faster recovery in bacterial illnesses
Composition
CEFPODOXIME PROXETI-50 MG, POTASSIUM CLAVULANATE-31.25 MG DRY SYP
Benefits
CEFPONIL-50 CV DRY SYP offers broad-spectrum and enhanced antibacterial protection against resistant bacterial strains. It is highly effective in treating pediatric conditions such as bronchitis, tonsillitis, sinusitis, otitis media, and uncomplicated urinary tract infections. The addition of Clavulanate ensures successful treatment even in cases where standard antibiotics may fail due to resistance. Its pleasant taste and suspension form ensure ease of administration and improved adherence in children. With reliable efficacy and safety, CEFPONIL-50 CV DRY SYP is a preferred choice among pediatricians.
Introduction
CEFPONIL-50 CV DRY SYP is a pediatric antibiotic suspension combining Cefpodoxime Proxetil 50 mg, a third-generation cephalosporin, with Potassium Clavulanate 31.25 mg, a β-lactamase inhibitor. This combination enhances the antibiotic’s effectiveness by protecting Cefpodoxime from enzymatic degradation caused by β-lactamase–producing bacteria. CEFPONIL-50 CV DRY SYP is specially formulated as a palatable dry syrup for children and is indicated for the treatment of various bacterial infections including those of the respiratory tract, urinary tract, ENT (ear, nose, and throat), and skin.
